Reza Dana, M.D., M.P.H., M.Sc.

Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol 2008; 126: 219-225.

Cursiefen C. VEGF-A neutralization after high-risk corneal transplantation promotes graft survival. Arch Ophthalmol 2008; 126: 71-77.

Boisgérault F, Liu Y, Anosova N, Dana R, Benichou G. Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants. Transplantation 2009; 87: 16-23.

Ecoiffier T, El Annan J, Rashid S, Schaumberg DA, Dana R. Modulation of integrinAlpha-4 Beta-1 (VLA-4) in dry eye syndrome. Arch Ophthalmol 2008; 126:1695-9. PMID 19064851.

Chung ES, Saban DR, Chauhan SK, Dana R. Regulation of blood versus lymphatic growth in the cornea. Invest Ophthalmol Vis Sci. 2008; PMID 19029028.

Mantelli F, Schaffer L, Dana R, Argueso P. Glycogene expression in conjunctiva of patients with dry eye: downregulation of notch signaling. Invest Ophthalmol Vis Sci. 2008; PMID 19011014.

Chauhan SK, Saban DR, Lee HK, Dana R. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunology 2009; 182:148-153.

Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of Dry Eye Disease among US Men: Estimates from the Physicians’ Health Studies. Arch Ophthalmol 2009; 127(6):763-768.

Saban DR, Chauhan SK, Zhang X, El Annan J, Jin Y, Dana R. Chimeric grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival. Am J Transplantation 2009; 9: 473-483.

Chauhan SK, El Annan J, Ecoiffier T, Goyal S, Zhang Q, Saban DR, Dana R. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunology 2009; 182: 1247-1252.

Goyal S, Chauhan SK, Zhang Q, Dana R. Topical antagonist to chemokine receptor CCR2 ameliorates murine dry eye disease. Arch Ophthalmol 2009; 127:882-887.

Langston D, Dana, R. Topical Bevacizumab in the treatment of corneal neovascularization: results of a prospective open-label, non-comparative study. Arch Ophthalmol 2009; 127(4):381-389.

Zhang X, Shen L, Jin Y, Saban DR, Chauhan SK, and Dana R. Depletion of passenger leukocytes from corneal grafts: An effective means of promoting transplant survival? Invest Ophthalmol Vis Sci, 2009; in press.

Bachmann BO, Luetjen-Drecoll E, Bock F, Wiegand SJ, Hos D, Dana R, Kruse FE, Cursiefen C. Transient postoperative VEGF-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation. Br J Ophthalmol 2009; [Epub ahead of print PMID 19224901].

Fabiani C, Barabino S, Rashid S, Dana MR. Corneal epithelial proliferation and thickness in a mouse model of dry eye. Exp Eye Res 2009; 89: 166-171. PMID: 19298814.

Hamrah P, Haskova Z, Taylor AW, Zhang Q, Ksander BR, Dana MR. Local treatment with alpha-melanocyte stimulating hormone reduces corneal allorejection. Transplantation, 2009: in press.

Dastjerdi MH, Hamrah P, Dana R. High frequency topical Cyclosporine 0.05% in treatment of severe dry eye refractory to twice daily regimen. Cornea 2009; in press.

Chauhan SK, Dana R. Role of Th17 cells in the immunopathogenesis of dry eye disease. Mucosal Immunology 2009; 2(4):375-376.

Jin Y, Arita M, Zhang Q, Saban DR, Chauhan SK, Chiang N, Serhan CN, Dana R. Novel Anti-inflammatory and Pro-resolving Lipid Mediators Block Inflammator Angiogenesis. Invest Ophthalmol Vis Sci. 2009 Apr 30. [Epub ahead of print PMID: 19407006].

 Jin Y, Chauhan SK, Saban DR, Dana R. Role of CCR7 in facilitating direct allosensitization
and regulatory T cell function in high-risk corneal transplantation. Invest Ophthalmol Vis Sci. 2009; in press.

Chung ES, Chauhan SK, Jin Y, Nakao S, Hafezi-Moghadam A, van Rooijen N, Zhang Q, Chen L, Dana R. Mechanisms of neovascularization induced by VEGFR-3 specific ligands. Am J Pathol, Submitted.

Dastjerdi M, Saban DR, Okanobo A, Nallasamy N, Sadrai Z, Chauhan SK, Hajrasouliha A, Dana R. Effects of topical and subconjunctival bevacizumab (Avastin) in high-risk corneal transplant survival. Invest Ophthalmol Vis Sci 2009; in press.

Skobe M, Dana R. Endogenous inhibitor to corneal lymphangiogenesis [Perspectives Article]. Nature Med 2009; in press.

Lee HK, Chauhan SK, Kay ED, Dana R. Flt-1 regulates cell migration via a protein tyrosine kinase-7-dependant pathway. Blood, Submitted.

Mantelli F, Schaffer L, Dana R, Head SR, Argüeso P. Glycogene expression in conjunctiva of patients with dry eye: Downregulation and notch signaling. Invest Ophthalmol Vis Sci 2009; 50(6):2666-2672.